STOCK TITAN

Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings

Zomedica Corp. (ZOMDF), a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, has scheduled its Q1 2025 earnings conference call for Thursday, May 15, 2025, at 4:30 p.m. ET. The call will cover operational and financial highlights for the quarter ended March 31, 2025, followed by a Q&A session.

Participants can join via phone at +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International). A replay will be available until May 29, 2025, accessible by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International) with pin 1148151.

Zomedica Corp. (ZOMDF), un'azienda nel settore della salute veterinaria specializzata in prodotti diagnostici e terapeutici point-of-care per animali equini e da compagnia, ha programmato la sua conference call per i risultati del primo trimestre 2025 per giovedì 15 maggio 2025 alle 16:30 ET. La chiamata tratterà i principali dati operativi e finanziari relativi al trimestre conclusosi il 31 marzo 2025, seguita da una sessione di domande e risposte.

I partecipanti potranno unirsi telefonicamente chiamando il numero +1-800-717-1738 (numero verde USA) o +1-646-307-1865 (internazionale). La registrazione della chiamata sarà disponibile fino al 29 maggio 2025, accessibile componendo il numero +1-844-512-2921 (USA) o +1-412-317-6671 (internazionale) con il pin 1148151.

Zomedica Corp. (ZOMDF), una empresa de salud veterinaria especializada en productos diagnósticos y terapéuticos point-of-care para animales equinos y de compañía, ha programado su conferencia telefónica de resultados del primer trimestre de 2025 para el jueves 15 de mayo de 2025 a las 4:30 p.m. ET. La llamada cubrirá los aspectos operativos y financieros del trimestre finalizado el 31 de marzo de 2025, seguida de una sesión de preguntas y respuestas.

Los participantes pueden unirse por teléfono llamando al +1-800-717-1738 (línea gratuita en EE.UU.) o al +1-646-307-1865 (internacional). Una repetición estará disponible hasta el 29 de mayo de 2025, accesible marcando +1-844-512-2921 (EE.UU.) o +1-412-317-6671 (internacional) con el pin 1148151.

Zomedica Corp. (ZOMDF)는 말과 반려동물을 위한 현장 진단 및 치료 제품을 전문으로 하는 수의학 건강 회사로, 2025년 1분기 실적 컨퍼런스 콜2025년 5월 15일 목요일 오후 4시 30분 ET에 예정하고 있습니다. 이번 콜에서는 2025년 3월 31일로 종료된 분기의 운영 및 재무 하이라이트를 다루며, 이후 질의응답 시간이 이어집니다.

참석자는 미국 무료 전화 +1-800-717-1738 또는 국제 전화 +1-646-307-1865로 참여할 수 있습니다. 재청취는 2025년 5월 29일까지 가능하며, +1-844-512-2921(미국) 또는 +1-412-317-6671(국제) 번호에 핀 1148151을 입력하여 접속할 수 있습니다.

Zomedica Corp. (ZOMDF), une entreprise spécialisée dans la santé vétérinaire proposant des produits diagnostiques et thérapeutiques point-of-care pour les chevaux et les animaux de compagnie, a programmé sa conférence téléphonique sur les résultats du premier trimestre 2025 pour le jeudi 15 mai 2025 à 16h30 ET. L'appel couvrira les points forts opérationnels et financiers du trimestre clos le 31 mars 2025, suivi d'une séance de questions-réponses.

Les participants peuvent rejoindre la conférence par téléphone au +1-800-717-1738 (numéro vert aux États-Unis) ou au +1-646-307-1865 (international). Une rediffusion sera disponible jusqu'au 29 mai 2025, accessible en composant le +1-844-512-2921 (États-Unis) ou le +1-412-317-6671 (international) avec le code 1148151.

Zomedica Corp. (ZOMDF), ein Unternehmen im Bereich der veterinärmedizinischen Gesundheitsversorgung, das sich auf Point-of-Care-Diagnostik- und Therapieprodukte für Pferde und Begleittiere spezialisiert hat, hat seine Telefonkonferenz zu den Quartalsergebnissen Q1 2025 für Donnerstag, den 15. Mai 2025 um 16:30 Uhr ET angesetzt. Die Telefonkonferenz behandelt operative und finanzielle Highlights für das Quartal zum 31. März 2025, gefolgt von einer Fragerunde.

Teilnehmer können sich telefonisch unter +1-800-717-1738 (gebührenfrei in den USA) oder +1-646-307-1865 (international) einwählen. Eine Aufzeichnung steht bis zum 29. Mai 2025 zur Verfügung und ist unter +1-844-512-2921 (USA) oder +1-412-317-6671 (international) mit der PIN 1148151 abrufbar.

Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESS Newswire / May 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2025. A question-and-answer session will follow management's prepared remarks.

Event: Zomedica First Quarter 2025 Earnings Call

Date: Thursday, May 15, 2025

Time: 4:30 p.m. Eastern Time

Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)

Webcast: LINK

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, May 29, 2025 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1148151.

About Zomedica

Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices, along with the TRUFORMA® diagnostic platform, TRUVIEW® digital cytology system, VETGuardian® no-touch monitoring system, and VETIGEL® hemostatic gel, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. Zomedica grew revenue 8% in 2024 to $27 million and maintains a strong balance sheet with approximately $71 million in liquidity as of December 31, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit www.zomedica.com.

Follow Zomedica

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on ACCESS Newswire

FAQ

When is Zomedica (ZOMDF) reporting Q1 2025 earnings?

Zomedica (ZOMDF) will report Q1 2025 earnings on Thursday, May 15, 2025, at 4:30 p.m. ET.

How can I join Zomedica's Q1 2025 earnings call?

You can join by calling +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International).

What is the replay information for Zomedica's Q1 2025 earnings call?

The replay will be available until May 29, 2025, by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International) with pin 1148151.

What does Zomedica (ZOMDF) company do?

Zomedica is a veterinary health company that provides point-of-care diagnostic and therapeutic products for equine and companion animals.
Zomedica Corp

OTC:ZOMDF

ZOMDF Rankings

ZOMDF Latest News

ZOMDF Stock Data

68.69M
958.66M
1.87%
9.37%
4.63%
Medical Devices
Healthcare
Link
United States
Ann Arbor